p38 MAP kinase alpha inhibitors (Attenuon)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namep38 MAP kinase alpha inhibitors (Attenuon)
Drug Alias NameATN-1101ATN-1114ATN-1100ATN-1124
ClassificationSmall molecules
Mechanisms of ActionP38 α mitogen-activated protein kinase inhibitorsAnticancer protein kinase inhibitors
TargetsP38 α mitogen-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAttenuon Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAttenuon Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A